Treating neurological patients during the pandemic period has become extremely challenging. At the same time, responding properly to these challenges has been diverse around the world, with varying levels of readiness, discipline, and approach. Additionally, there are significant differences in healthcare resources and processes between nations, and even within a nation, and these have significantly influenced the treatment procedure throughout the pandemic. However, neurologists have been called to care for patients with neurological symptoms who have COVID-19, and to continue managing COVID-19-affected neurological comorbidities in patients as before. This study highlights how the treatment procedures for neurological diseases are rapidly changing due to the spread of the SARS-CoV-2 virus. It also focuses on the challenges healthcare professionals are facing while providing proper treatment to neurological patients during the pandemic situation. Lastly, it offers some useful recommendations regarding the effective management of neurological diseases during the COVID-19 pandemic period.
Citation: Scott Mendoza. Adapting patient treatment of neurological diseases during the COVID-19 pandemic[J]. AIMS Neuroscience, 2023, 10(2): 75-86. doi: 10.3934/Neuroscience.2023006
Treating neurological patients during the pandemic period has become extremely challenging. At the same time, responding properly to these challenges has been diverse around the world, with varying levels of readiness, discipline, and approach. Additionally, there are significant differences in healthcare resources and processes between nations, and even within a nation, and these have significantly influenced the treatment procedure throughout the pandemic. However, neurologists have been called to care for patients with neurological symptoms who have COVID-19, and to continue managing COVID-19-affected neurological comorbidities in patients as before. This study highlights how the treatment procedures for neurological diseases are rapidly changing due to the spread of the SARS-CoV-2 virus. It also focuses on the challenges healthcare professionals are facing while providing proper treatment to neurological patients during the pandemic situation. Lastly, it offers some useful recommendations regarding the effective management of neurological diseases during the COVID-19 pandemic period.
| [1] |
Matías-Guiu J, Porta-Etessam J, Lopez-Valdes E, et al. (2020) Management of neurological care during the COVID-19 pandemic. Neurología (English Edition) 35: 233-237. https://doi.org/10.1016/j.nrleng.2020.04.001 
|
| [2] |
Orsini A, Corsi M, Santangelo A, et al. (2020) Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients. Neurol Sci 41: 2353-2366. https://doi.org/10.1007/s10072-020-04544-w
|
| [3] | Mao L, Jin H, Wang M, et al. (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77: 1-9. https://doi.org/10.1001/jamaneurol.2020.1127 |
| [4] |
Nordvig AS, Fong KT, Willey JZ, et al. (2021) Potential neurologic manifestations of COVID-19. Neurology: Clin Pract 11: e135-e146. https://doi.org/10.1212/CPJ.0000000000000897
|
| [5] |
Avula A, Nalleballe K, Narula N, et al. (2020) COVID-19 presenting as stroke. Brain Behav Immun 87: 115-119. https://doi.org/10.1016/j.bbi.2020.04.077
|
| [6] |
Markus HS, Brainin M (2020) COVID-19 and stroke—A global World Stroke Organization perspective. Int J Stroke 15: 361-364. https://doi.org/10.1177/1747493020923472
|
| [7] |
Paterson RW, Brown RL, Benjamin L, et al. (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 143: 3104-3120. https://doi.org/10.1093/brain/awaa240
|
| [8] |
Pilotto A, Benussi A, Libri I, et al. (2021) COVID-19 impact on consecutive neurological patients admitted to the emergency department. J Neurol Neurosur Ps 92: 218-220. https://doi.org/10.1136/jnnp-2020-323929
|
| [9] |
Moro E, Fernandez HH (2020) Adaptive neurology in COVID-19 times. Parkinsonism Relat D 75: 124-125. https://doi.org/10.1016/j.parkreldis.2020.06.003
|
| [10] |
Chen PM, Hemmen TM (2020) Evolving healthcare delivery in neurology during the coronavirus disease 2019 (COVID-19) pandemic. Front Neurol 11: 578. https://doi.org/10.3389/fneur.2020.00578
|
| [11] |
Zullo S, Ingravallo F, Crespi V, et al. (2021) The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system's preparedness. Neurol Sci 42: 799-804. https://doi.org/10.1007/s10072-020-04984-4
|
| [12] |
Venketasubramanian N, Anderson C, Ay H, et al. (2021) Stroke care during the COVID-19 pandemic: international expert panel review. Cerebrovasc Dis 50: 245-261. https://doi.org/10.1159/000514155
|
| [13] |
Alam MB (2021) Management Difficulties of Neurological Care during the COVID-19 Pandemic. J Natl Inst Neurosci Bangladesh 7: 1-2. https://doi.org/10.3329/jninb.v7i1.54742
|
| [14] |
Bhaskar S, Sharma D, Walker AH, et al. (2020) Acute Neurological Care in the COVID-19 Era: The Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium Pathway. Front Neurol 11: 579. https://doi.org/10.3389/fneur.2020.00579
|
| [15] |
von Oertzen TJ, Macerollo A, Leone MA, et al. (2021) EAN consensus statement for the management of patients with neurological diseases during the COVID-19 pandemic. Eur J Neurol 28: 7-14. https://doi.org/10.1111/ene.14521
|
| [16] | Stefanou M-I, Palaiodimou L, Bakola E, et al. (2022) Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis 13: 20406223221076890. https://doi.org/10.1177/20406223221076890 |
| [17] |
Maltezou HC, Pavli A, Tsakris A (2021) Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines 9: 497. https://doi.org/10.3390/vaccines9050497
|
| [18] |
Zawilska JB, Kuczyńska K (2022) Psychiatric and neurological complications of long COVID. J Psychiatr Res 156: 349-360. https://doi.org/10.1016/j.jpsychires.2022.10.045
|
| [19] |
Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. (2021) Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int J Env Res Pub He 18: 2621. https://doi.org/10.3390/ijerph18052621
|
Scott Mendoza. Adapting patient treatment of neurological diseases during the COVID-19 pandemic[J]. AIMS Neuroscience, 2023, 10(2): 75-86. doi: 10.3934/Neuroscience.2023006
DownLoad: